Novo Nordisk investing $117.4M in manufacturing site in Denmark

Novo Nordisk investing $117.4M in manufacturing site in Denmark

Source: 
Fierce Pharma
snippet: 

Novo Nordisk’s site in Kalundborg, Denmark, already manufactures about half of the world’s insulin, but with a DKK 800 million makeover the site will be able to produce even more insulin and other products.